During the past decade, Saratoga Cardiology Associates conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Saratoga Cardiology Associates" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Saratoga Cardiology Associates" are "Heart Failure" (1 trials), "Heart Failure With Preserved Ejection Fraction" (1 trials) and "Obesity" (1 trials). Many other conditions were trialed in "Saratoga Cardiology Associates" in a lesser frequency.

Most popular intervention types in "Saratoga Cardiology Associates" are "Other" (2 trials), "Device" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Biomarker-guided care NT-proBNP" (1 trials), "Placebo" (1 trials), "Tirzepatide" (1 trials) and "Usual Care" (1 trials). Other intervention names were less common.

The vast majority of trials in "Saratoga Cardiology Associates" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Saratoga Cardiology Associates". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Saratoga Cardiology Associates, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Saratoga Cardiology Associates, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".